Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Need cash fast? Explore effective ways to earn money today and improve your financial situation quickly.
23,263 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Tripadvisor (TRIP) entered 2026 with a clear path: optimize advertising, expand bookings, and monetize experiences. I...
When insiders move stock, investors pay attention. This article breaks down what iradimed’s founder sold 7,500 means ...
Palantir (PLTR) sits near $152 after a blowout Q1 2026. Investors weigh whether to buy, hold, or sell Palantir stock ...
A director quietly sold a notable stake in American Superconductor, prompting questions about what it signals for inv...
Uber trades lower after peaking earlier in the year, but quarterly earnings rose sharply as the company leans into au...
As July nears, chatter over SpaceX joining the Nasdaq-100 swirls. This article argues that a bigger, more reliable ca...
The REX AI Equity Premium Income ETF delivers a high headline payout, but its covered-call approach trails the AI ral...
Sandisk surged more than 3,000% in the past year, turning heads and raising questions about valuation and future move...
As AI-driven data center needs surge, Micron could defy typical cycles. This guide lays out why prediction: micron st...
Vertiv rode a powerful wave in February as AI-driven data-center demand accelerated and the company highlighted durab...
As 2026 unfolds with economic and geopolitical headwinds, investors look to five Dividend Aristocrats for steady inco...